Avecia Pharma Llp - Company Profile

It is a business services limited liability partnership based in Mumbai, Maharashtra, India, established in 2016.
2016 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Avecia Pharma Llp

Avecia Pharma Llp, a struck off limited liability partnership, was established on 28 May 2016 in Mumbai, Maharashtra, India. Engaging in other services within the business services sector, it holds LLPIN: AAG-4960. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Richa Ravi Agrawal (Designated Partner), Smriti Rajesh Agrawal (Designated Partner), Manisha Yogesh Agrawal (Designated Partner). Its latest date of accounts and solvency statement 31 March 2019. It is based at 98, Industrial Area Charkop, Kandivali West, Mumbai, Maharashtra, 400067.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAG-4960

  • Incorporation Date

    28 May 2016

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Struck Off

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 9 Year, 9 Months
  • Last Filing with ROC 31 Mar 2019
Company report

Avecia Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Avecia Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Avecia Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Richa Ravi Agrawal Designated Partner 28 May 2016 Current
Smriti Rajesh Agrawal Designated Partner 28 May 2016 Current
Manisha Yogesh Agrawal Designated Partner 28 May 2016 Current
Aayush Madhusudan Agrawal Designated Partner 28 May 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Avecia Pharma Llp.

Enhance accessibility to Avecia Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Avecia Pharma Llp revenue growth over time
Avecia Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Avecia Pharma Llp?

Unlock access to Avecia Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Avecia Pharma Llp?

Unlock and access historical data on people associated with Avecia Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Avecia Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avecia Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Avecia Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Avecia Pharma Llp last Annual general meeting of members was held on 31 Mar 2019 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    The activity Avecia Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Mumbai. was completed.

  • Director Appointment

    The activity Richa Ravi Agrawal was appointed as a Designated Partner was appointed as a Designated Partner on 28 May 2016 & has been associated with this company since 9 years 9 months . was completed.

  • Director Appointment

    Smriti Rajesh Agrawal was appointed as a Designated Partner was appointed as a Designated Partner on 28 May 2016 & has been associated with this company since 9 years 9 months . was recorded as a recent event.

  • Director Appointment

    Progress on Manisha Yogesh Agrawal was appointed as a Designated Partner was appointed as a Designated Partner on 28 May 2016 & has been associated with this company since 9 years 9 months . was documented.

  • Director Appointment

    Aayush Madhusudan Agrawal was appointed as a Designated Partner was appointed as a Designated Partner on 28 May 2016 & has been associated with this company since 9 years 9 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Avecia Pharma Llp?

The LLPIN of Avecia Pharma Llp is AAG-4960.

Where is Avecia Pharma Llp headquartered?

Avecia Pharma Llp is headquartered at 98, Industrial Area Charkop, Kandivali West, Mumbai, Maharashtra, 400067.

When was Avecia Pharma Llp incorporated?

Avecia Pharma Llp was incorporated on 28 May 2016.

Who are the current directors of Avecia Pharma Llp?

The current directors of Avecia Pharma Llp are

What is the primary industry of Avecia Pharma Llp?

The primary industry of Avecia Pharma Llp is Business Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available